Seres Therapeutics, Inc. earnings per share and revenue

MCRB earnings per share for the last quarter are -0.27 USD whereas the estimation was -0.34 USD which accounts for 20.98% surprise. Företagets omsättning för samma period uppgår till 0.00 USD trots den uppskattade siffran 250.00 k USD. Estimated earnings per share for the next quarter are -0.29 USD, and revenue is expected to reach -226.14 k USD. Also watch annual changes over time to get a bigger picture of MCRB earnings per share and revenue dynamics.